Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
US10527604B1 · kind B1 · utility
9Cited by
68References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2016 |
| Grant date | Jan 7, 2020 |
| Priority date | — |
| Expiry date | Apr 18, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2021/3595
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides methods of assessing suitability of a pharmaceutical composition for medical use. The pharmaceutical composition comprises nanoparticles comprising paclitaxel coated with albumin and a non-nanoparticle portion comprising albumin and paclitaxel.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.